13 December 2022
finnCap Group plc ("finnCap" or the "Company")
Interim Results for the six months ended 30 September 2022
Diversification Delivered - Performance remains in line with management expectations
H1 23 Operational Overview
· Diversification strategy continues to deliver with over 80% of deal fees from non-ECM services
o Diversification has created a more resilient business - we are no longer a traditional corporate broker
o Focus remains on building a sector-focused financial advisory firm
o Key services include: public and private M&A; public equity advisory, fund raising and related activities; private capital raising; and debt advisory
o Continue to make selective hires to strengthen capability whilst managing the cost base cautiously
o Expansion into advisory areas outside our key service areas has been de-prioritised
· Delivering for clients: 33 transactions in H1 23 with aggregate deal value of £740m
o Raised c.£80m equity through 10 public market placings (H1 22: 14 deals; £250m raised)
o Advised on 11 private M&A deals with aggregate value of c.£430 million (H1 22: 13; £1bn)
o Advised on 4 public company M&A deals with an aggregate value of c.£75m (H1 22: 4; £500m)
o Completed 8 debt financing mandates raising c.£160m (H1 22: 6 deals raising c.£250m)
· Controlling our costs
o Significant reduction in fixed cost base implemented from September 2022
o FY24 fixed cost base substantially reduced to c.£28m from c.£31.5m H123 run rate(2)
o Reduced discretionary spend and headcount reduction without impacting client service levels
o Marketing of surplus office space under way, further savings identified
· Challenging operating environment
o UK equity issuance subdued since the invasion of Ukraine - H1 23 decline in AIM issuance of c.70%(3)
o Significant economic uncertainty with rising interest rates and inflation impacting investor confidence
o Private and plc M&A activity has continued but deal financing has become more challenging
H1 23 - Financial Highlights
o Total revenue £16.4m (H1 22: £31.7m) down 48% vs H1 22 our record half year revenue performance
o finnCap Capital Markets revenue £9.3m (H122: £15.6m)
o finnCap Cavendish revenue £7.1m (H121: £16.1m) in line with 5 year average HY level
o Adjusted PBT(1) of £(0.6)m (H1 22: Adjusted PBT of £7.2m); PBT of £(2.6)m (H1 22: PBT£6.3m)
o Adjusted basic EPS:(1) (0.30)p (H1 22: 3.54p); Basic EPS: (1.82)p (H1 22: 2.96p)
o Cash balance: £11.1m at 30 September 2022 (31 March 22: £24.4m) post investment in Energise Limited; FY22 corporation tax and FY22 discretionary compensation payments
Current Trading
· Q3 trading remains in line with our full year expectations
· Deal pipeline remains solid and continues to grow with equity fund raisings, potential VCT eligible IPOs and private M&A transactions scheduled to complete in the coming months
FY23 Interim and Full Year Dividends
o Board remains committed to paying attractive dividends to shareholders
o However, in light of the uncertain economic environment, no interim dividend will be paid and the decision on dividends for FY23 will be made in conjunction with the publication of FY23 final results
Commenting on the results, John Farrugia, Chief Executive Officer, said:
"Today's results demonstrate the resilience of our diversified business model and that our strategy of building a broader-based financial advisory firm has benefitted us during this sharp downturn. We have delivered a good H1 private and public M&A performance helping to offset the well publicised weakness in the equity issuance market which is affecting all of our competitors. Despite the challenging macro environment, our H1 results were in line with our expectations and the Group continued to deliver for clients executing 31 transactions with an aggregate value of c.£700m .
It is likely that these adverse conditions will continue for some time and we have therefore taken appropriate steps to reduce our fixed operating cost base by managing discretionary spending and reducing headcount across all functions of the firm to align it with the opportunity we see ahead of us. These cost savings have already been implemented and the Group is now re-set and focused on building positive momentum.
Relative to H1, Q3 has begun well with the ECM team closing a number of equity fund raisings, including for Xeros Technologies and Surface Transforms, the completion of the acquisition of Attraqt PLC and private M&A transactions including the sale of Peach Pubs. Our pipeline of private M&A transactions remains good and we currently have over 36 mandates signed and in various stages of execution.
Given the uncertain operating environment, no interim dividend will be paid and we will make a decision on a final dividend for FY23 once we have completed the year and have greater clarity on the outlook for the business and our industry in 2023."
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
Contacts
finnCap Group plc Tel: +44 (0) 20 7220 0500
John Farrugia, Chief Executive Officer investor.relations@finncap.com
Richard Snow, Chief Financial Officer
Grant Thornton (Nominated Adviser) Tel: +44 (0) 20 7383 5100
Philip Secrett/Samantha Harrison/George Grainger
Oberon Capital (Joint broker) Tel: +44 (0) 20 3179 5344
Mike Seabrook
finnCap Ltd (Joint Broker) Tel: +44 (0) 20 7220 0500
Rhys Williams / Tim Redfern
Hudson Sandler (PR adviser) Tel: +44 (0) 20 7796 4133
Dan de Belder/Rebekah Chapman
Notes to Editors
About finnCap Group
finnCap Group is a diversified financial advisory firm offering a full range of services across M&A advice, equity and debt capital raising and related services to corporate and institutional clients and high net worth investors including private equity and family offices. It has particular strength in the technology, life sciences, consumer and business services sectors. finnCap Group has global reach through its affiliation with the Oaklins partnership and access to net zero and carbon economy consultancy through its partnership with Energise Limited.
Notes: (1) Adjusted LBT, PBT and EPS are calculated excluding share-based payments, amortisation of intangible assets from the acquisition of Cavendish Corporate Finance LLP, non-recurring costs and includes, for EPS, an adjustment to normalise tax. The weighted average number of shares in issue during the period excludes shares held by the Group's Employee Benefit Trust.
(2) Being total fixed employee costs (ie excluding IFRS 2 share-based payments charges and discretionary compensation) plus non-employee costs.
(3) AIM placings >£5m per London Stock Exchange to 30 September 2022.
Diversity of services - a key strength in a challenging equity environment
The operating environment in H1 2023 could not contrast more sharply with H1 2022 - when we delivered our best ever half-yearly results with strong revenues from both the ECM and M&A teams.
Since the invasion of Ukraine, a combination of economic uncertainty, sharply rising inflation and rising interest rates have hit investor confidence and the volume of UK equity issuance - our key driver of ECM revenues - which has fallen substantially from recent, record levels. In H123, overall equity issuance on AIM in H1 was c.£0.8bn (H122: £3.0bn) (source: London Stock Exchange).
The Group's strategy of diversification into new products and services, in particular the private M&A market through its acquisition of Cavendish, coupled with our plc M&A franchise and debt advisory team, means that we are continuing to bring in good levels of revenue despite weakness in the equity issuance market. We believe that, with c.90% of deal fees being earned outside the core ECM business our performance in this period will be comparatively better than our ECM focused peers.
Overall, we have been active for our clients executing 33 transactions with an aggregate deal value of £740m (H1 22: 37 transactions with an aggregate value of £2bn).
Our balance sheet remains strong and in line with our liquidity objective at the half year with the reduction from March's balance being driven by payment of year-end discretionary compensation, corporation tax and the Group's investment in Energise Limited.
Divisional performance - delivering for our clients
finnCap Capital Markets (ECM) generated £9.3m in H122 (H122: £15.6m).
Retainers - Total fees from retainers in the period increased to £3.5m (H122: £3.2m) driven by RPI adjustments to annual ECM retainers. Client numbers were broadly stable at 118 (H1 22: 116) with several new clients currently in our formal take-on process.
Transactions - Total fees received from transactions in the period were £3.9m (H122: £8.7m).
In the half year, finnCap Capital Markets raised over £70m (H1 22: £250m) across 11 (H1 22: 14) equity fundraisings for listed clients. The plc advisory team completed 4 transactions with an aggregate value of c.£80m and the debt advisory team, which works across both finnCap Capital Markets and finnCap Cavendish, completed 8 fund-raising mandates raising c.£160m and billing over £0.6m in line with last year.
Trading - Trading revenues were £1.9m (H1 22: £3.7m), reducing in line with the wider equity issuance markets, market volumes and activity decreased during H1.
Despite this backdrop, our pipeline of potential transactions in ECM remains good - with many of our clients needing to raise equity to fund growth and strengthen their own balance sheets and continued plc M&A activity where we have a strong franchise. In ECM, deal fee revenue trends have been better than in H1 and, although activity remains muted, we currently expect that ECM will deliver an H2 revenue performance in line or slightly ahead of H1. During H1 with lower ECM activity we have focused on client service. Although M&A activity has been high on AIM, client numbers remained stable in the period with 9 new client wins and four currently in take on.
finnCap Cavendish (M&A) delivered another good half year revenue performance closing 11 deals with an aggregate market value of c.£430m and with average success fees of c.£600k, near to our target level of £650k. As expected, this is well down on our record half year in H1 22 but overall performance was in line with 5 year average revenue levels. Although the financing of deals is currently more challenging than at the start of 2022, we see continued buyer confidence - both trade and private equity - and good competition for quality assets.
Overall finnCap Cavendish generated revenues of £7.1m (H1 22: £16.1m). Activity levels remain good and given our good pipeline, we currently expect that our H2 M&A revenue will be in line with or ahead of our H1 performance.
Strategy - transition from ECM corporate broker to strategic financial adviser complete
We remain committed to our strategy of broadening and deepening our strategic financial advisory capabilities through development of our in-house teams and selective hiring where appropriate. We believe that this strategy - implemented over several years - has created a business better capable of mitigating the cyclicality of our original ECM focused corporate broking business model.
We will continue to deepen our sector-based approach to ensure that we maximise our relevance to clients be they institutional, private equity, corporate or high net worth individuals and focusing on those clients where we can be best equipped to deliver their objectives.
Whilst we will continue to consider potential M&A opportunities we expect that these will be focused on businesses and teams offering services within or directly adjacent to our existing financial services advisory offering. In the medium term we are unlikely to diversify away from this core focus and currently are not actively considering any acquisition opportunities.
Managing our costs for the current environment
After a period of strong revenue growth and investment in people, we have seen the fixed cost base in the business - employee costs excluding discretionary pay plus non-people operating expenses - rise from c.£22.0m in FY20 to c.£31.5m(2) in FY23, (annualising our H1 performance). This increase of c.50% is substantially ahead of our growth in headcount at 30 September (c.20%) and is driven by a number of factors including, high wage inflation in our sector for client facing staff; the cost of the Group's new property; higher corporate costs (eg insurance) and investment in better IT systems to support sales and trading, CRM and cyber risks.
With lower revenue and a more focused strategy, the Group undertook a focused restructuring programme in September - including both voluntary and mandatory redundancies - losing c.15 heads across all parts of the Group and at all levels. In addition, we have reviewed and cut our discretionary spend, in particular around marketing events and branding. We have also relocated teams more effectively within our new offices and are in the process of marketing surplus office space which should generate a further saving in the next financial year without preventing us selectively growing headcount when conditions permit.
In aggregate, we expect that the Group's fixed cost base(2) will be reduced to c.£28m for FY24.
Overall, in H1, administrative expenses decreased by c.31%. Employee benefit expense decreased by 41% and discretionary bonus payments for H1 were very limited. Staff costs as a percentage of revenue were c.67% reflecting the impact of much lower revenues
Non-employee costs in H1 were £5.7m (H1 22: £5.2m), up 10% - in line with our expectations and guidance for FY23 and reflects, in particular, higher IT costs (where software pricing inflation and investment in cyber security have been key drivers) and travel and marketing expenditure post the pandemic impacted period. Taking into account the benefits of the cost reduction measures we have taken in H1, we expect non-employee costs to be c.£10.5m (excluding third-party introductory fees) for FY23.
Non staff costs per employee - a key efficiency measure - was broadly stable at £36k (H1 22: £34k).
Energise full year revenues up 40%
Our joint venture Energise Limited ("Energise"), an energy efficiency and net zero consultancy, in which the Group invested c.£2m for a 50% interest in May, has completed its financial year to 30 September 2022. Unaudited revenue was £1.5m up c.40% on the prior year and Energise recorded a loss before taxation of c£0.3m in line with our expectations and consistent with its strategy to drive revenue growth through hiring consultants and driving client growth over the next 3 years.
Non-recurring expenditure
In H1 we incurred c.£1.4m of non-recurring expenditure with c.£1.2m for the headcount restructuring and CEO departure and c.£0.2m of legal and advisory fees related to the potential take-over with Panmure Gordon Group Limited which were mutually terminated in November.
There are expected to be further non-recurring items in H2 as certain of the employee settlements have been settled since the half year end and payments under some of the arrangements are contingent on a number of factors including mitigation clauses related to terms of subsequent re-employment.
Capital and liquidity position in line with our target
The Group's cash position at 30 September 2022 was £11.1m with the reduction from 31 March 2022 being driven by payment of discretionary compensation for FY22, the FY22 corporation tax liability, a basic fit out of our spare office space (making it suitable for sub-letting) and our £2.1m investment in Energise Limited. The underlying cash reduction was c.£1.3m. Cash is stated before the £1.0m balance of the fit-out loan which is payable in instalments over the next 3 years.
Maintaining a strong liquidity position and the longer-term financing of our office move means that the Group is better able to withstand challenging operating conditions such as those we are currently experiencing.
Operating responsibly
In August we held our second The Side Hustle competition with our partners ACCA and YourGamePlan providing the winning youth entrepreneurs with funding to grow their businesses and active mentoring by our corporate finance and marketing teams. We have agreed to continue sponsoring this competition and supporting YourGamePlan Limited with the creation and development of its entrepreneurship education materials.
In terms of supporting our broader community:
- In May we sponsored ten Ukrainian refugees to gain English language and UK accreditation through sponsorship of Refuaid - part of the Ukraine Business Consortium.
- We continue to support the Whitechapel Mission (an East London based charity that provides food, clothing and support for people in need) through employee volunteering.
- We provided a team to implement an organised canal clean up in East London.
We have now operated our Employee Volunteer scheme for over 18 months. In FY23, Staff members have volunteered over 200 hours acting as swimming judges, running winter coat collections, and raising money for a wide variety of charities important to them. We have also hosted client education events around ESG, targeting NEDs, executives and investors focused on ESG reporting .
Rewarding shareholders
The Board recognises the importance of income to its shareholders and intends to continue to pay attractive dividends where appropriate and, in October 2022, the Group paid £2m to shareholders as the final dividend for FY22.
However, given the uncertain operating environment, no interim dividend for FY23 will be paid and the decision on dividends for the current financial year will be taken with the publication of the Group's full year results.
Q3 Trading and Outlook
The equity issuance market remains subdued with investors being highly selective about deal participation and pricing. Trading volumes are also muted. However, in a very quiet market, we have completed two sizeable offerings in H2 including for Xeros Technologies plc and Surface Transforms PLC. Overall ECM deal fees are already at around 50% of those recorded in H1. In the context of this environment, our ECM performance has been good and the pipeline is in good shape.
Activity in the M&A market remains favourable albeit debt financing for larger private equity deals is more challenging. The M&A pipeline remains good and we currently have 36 mandates at various stages of execution. Revenue is building well and we expect H2 M&A revenue to exceed H1.
With a more efficient cost base and a solid balance sheet we are well placed to deliver a result for FY23 in line with our expectations and are confident in the long-term prospects for the Group.
John Farrugia
Chief Executive Officer
13 December 2022
Consolidated Statement of Comprehensive Income
Unaudited for the 6 months ended 30 September 2022
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
|
Notes |
|
|
|
Revenue |
2 |
16,352 |
31,687 |
52,545 |
Other operating (loss)/income |
3 |
(138) |
(26) |
13 |
Total income |
|
16,214 |
31,661 |
52,558 |
Administrative expenses |
4 |
(17,057) |
(25,120) |
(43,941) |
Operating (loss)/profit before non-recurring items |
|
(843) |
6,541 |
8,617 |
Non-recurring items |
5 |
(1,444) |
- |
- |
Operating (loss)/profit |
|
(2,287) |
6,541 |
8,617 |
Finance income |
|
22 |
6 |
12 |
Finance charge |
|
(242) |
(265) |
(524) |
Share of joint venture loss |
|
(85) |
- |
- |
(Loss)/Profit before taxation |
|
(2,592) |
6,282 |
8,105 |
Taxation |
|
(487) |
(1,484) |
(1,594) |
(Loss)/Profit attributable to equity shareholders |
|
(3,079) |
4,798 |
6,511 |
Total comprehensive (loss)/income for the period |
|
(3,079) |
4,798 |
6,511 |
Consolidated Statement of Financial Position
Unaudited as at 30 September 2022
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
Non-current assets |
|
|
|
|
Property, plant and equipment |
|
12,518 |
13,833 |
13,304 |
Intangible assets |
|
13,514 |
13,372 |
13,512 |
Investment in joint venture |
|
2,218 |
- |
- |
Financial assets held at fair value |
|
729 |
635 |
802 |
Deferred tax asset |
8 i) |
133 |
888 |
620 |
Total non-current assets |
|
29,112 |
28,728 |
28,238 |
Current assets |
|
|
|
|
Trade and other receivables |
8 ii) |
11,186 |
12,725 |
13,074 |
Current assets held at fair value |
|
213 |
967 |
871 |
Cash and cash equivalents |
|
11,124 |
22,588 |
24,435 |
Total current assets |
|
22,523 |
36,280 |
38,380 |
Total assets |
|
51,635 |
65,008 |
66,618 |
|
|
|
|
|
Non-Current liabilities |
|
|
|
|
Lease liability |
|
10,829 |
13,876 |
11,151 |
Borrowings |
|
667 |
1,037 |
851 |
Provisions |
|
30 |
261 |
94 |
Total non-Current liabilities |
|
11,526 |
15,174 |
12,096 |
Current liabilities |
|
|
|
|
Trade and other payables |
|
9,122 |
15,158 |
20,389 |
Corporation taxation |
|
- |
1,600 |
714 |
Borrowings |
|
364 |
343 |
356 |
Total current liabilities |
|
9,486 |
17,101 |
21,459 |
Equity |
|
|
|
|
Share capital |
|
1,811 |
1,779 |
1,799 |
Share premium |
|
1,716 |
1,355 |
1,475 |
Own shares held |
8 iii) |
(1,926) |
(1,726) |
(1,926) |
Merger relief reserve |
8 iv) |
10,482 |
10,482 |
10,482 |
EBT Reserve |
|
(338) |
- |
(322) |
Share based payments reserve |
|
1,588 |
1,964 |
1,294 |
Retained earnings |
|
17,290 |
18,879 |
20,261 |
Total equity |
|
30,623 |
32,733 |
33,063 |
Total equity and liabilities |
|
51,635 |
65,008 |
66,618 |
Consolidated Statement of Cash Flows
Unaudited for the 6 months ended 30 September 2022
|
6 months ended |
6 months ended |
12 months ended |
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
Unaudited |
Unaudited |
Audited |
|
£'000 |
£'000 |
£'000 |
Cash flows from operating activities |
|
|
|
(Loss)/Profit before taxation |
(2,592) |
6,282 |
8,105 |
Adjustments for: |
|
|
|
Depreciation |
891 |
845 |
1,739 |
Amortisation of intangible assets |
31 |
74 |
83 |
Finance income |
(22) |
(6) |
(12) |
Finance charge |
242 |
265 |
524 |
Share based payments charge |
386 |
832 |
1,100 |
Net fair value gains/(loss) recognised in profit or loss |
138 |
26 |
(55) |
Payments received for non-cash assets |
(15) |
- |
(448) |
|
(941) |
8,318 |
11,036 |
Changes in working capital: |
|
|
|
(Increase)/Decrease in trade and other receivables |
1,888 |
(4,945) |
(5,292) |
(Decrease)/Increase in trade and other payables |
(10,420) |
1,008 |
4,456 |
(Decrease)/Increase in provisions |
(64) |
166 |
(1) |
Cash (outflow)/inflow generated from operations |
(9,537) |
4,547 |
10,199 |
Net cash receipts/(payment)s for current asset investments held at fair value through profit or loss |
658 |
(1,039) |
(943) |
Tax paid |
(1,141) |
(632) |
(1,628) |
Net cash (outflow)/inflow from operating activities |
(10,020) |
2,876 |
7,628 |
Cash flows from investing activities |
|
|
|
Purchase of property, plant and equipment |
(112) |
(74) |
(454) |
Purchase of intangible assets |
(25) |
(46) |
(182) |
Investment in Joint Venture |
(2,022) |
- |
- |
Proceeds on sale of investments |
- |
1,186 |
1,515 |
Interest received |
22 |
6 |
12 |
Net cash (outflow)/inflow from investing activities |
(2,137) |
1,072 |
891 |
Cash flows from financing activities |
|
|
|
Equity dividends paid |
- |
(1,638) |
(2,639) |
Proceeds from exercise of options |
3 |
441 |
581 |
Purchase of own shares |
- |
- |
(843) |
Interest paid |
(21) |
(27) |
(51) |
Lease liabilities payments |
(960) |
(400) |
(1,223) |
Net repayment of borrowings |
(176) |
(170) |
(343) |
Net cash outflow from financing activities |
(1,154) |
(1,794) |
(4,518) |
Net (decrease)/increase in cash and cash equivalents |
(13,311) |
2,154 |
4,001 |
Cash and cash equivalents at beginning of period |
24,435 |
20,434 |
20,434 |
Cash and cash equivalents at end of period |
11,124 |
22,588 |
24,435 |
|
|
|
|
Reconciliation of net debt |
|
|
|
Net increase in cash and cash equivalents |
(176) |
(170) |
(343) |
Borrowings at beginning of period |
1,207 |
1,550 |
1,550 |
Borrowings at end of period |
1,031 |
1,380 |
1,207 |
Consolidated Statement of Changes in Equity
Unaudited for the 6 months ended 30 September 2022
|
|
|
Own |
|
Merger |
Share Based |
|
|
|
Share |
Share |
Shares |
EBT |
Relief |
Payment |
Retained |
Total |
|
Capital |
Premium |
Held |
Reserve |
Reserve |
Reserve |
Earnings |
Equity |
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
Balance at 31 March 2021 |
1,737 |
956 |
(1,726) |
- |
10,482 |
1,132 |
15,719 |
28,300 |
Total comprehensive income for the period |
- |
- |
- |
- |
- |
- |
4,798 |
4,798 |
Transactions with owners: |
|
|
|
|
|
|
|
|
Share based payments charge |
- |
- |
- |
- |
- |
832 |
- |
832 |
Dividends |
- |
- |
- |
- |
- |
- |
(1,638) |
(1,638) |
Share options exercised |
42 |
399 |
- |
- |
- |
- |
- |
441 |
|
42 |
399 |
- |
- |
- |
832 |
(1,638) |
(365) |
Balance at 30 September 2021 |
1,779 |
1,355 |
(1,726) |
- |
10,482 |
1,964 |
18,879 |
32,733 |
Total comprehensive income for the period |
- |
- |
- |
- |
- |
- |
1,713 |
1,713 |
Transactions with owners: |
|
|
|
|
|
|
|
|
Share based payments charge |
- |
- |
- |
|
- |
268 |
- |
268 |
Deferred tax on share-based payments |
- |
- |
- |
|
- |
- |
(268) |
(268) |
Purchase of shares |
- |
- |
(843) |
|
- |
- |
- |
(843) |
EBT Gift |
- |
- |
- |
100 |
- |
- |
- |
100 |
Dividends |
- |
- |
- |
|
- |
- |
(1,001) |
(1,001) |
Share options exercised |
20 |
120 |
643 |
(422) |
- |
(938) |
938 |
361 |
|
20 |
120 |
(200) |
(322) |
- |
(670) |
(331) |
(1,383) |
Balance at 31 March 2022 |
1,799 |
1,475 |
(1,926) |
(322) |
10,482 |
1,294 |
20,261 |
33,063 |
Total comprehensive loss for the period |
- |
- |
- |
(16) |
- |
- |
(3,063) |
(3,079) |
Transactions with owners: |
|
|
|
|
|
|
|
|
Share based payments charge |
- |
- |
- |
- |
- |
386 |
- |
386 |
Investment in Join Venture |
9 |
241 |
- |
- |
- |
- |
- |
250 |
Share options exercised |
3 |
- |
- |
- |
- |
(92) |
92 |
3 |
|
12 |
241 |
- |
- |
- |
294 |
92 |
639 |
Balance at 30 September 2022 |
1,811 |
1,716 |
(1,926) |
(338) |
10,482 |
1,588 |
17,290 |
30,623 |
Notes to the Financial Statements
Unaudited for the 6 months ended 30 September 2022
1. Basis of preparation
finnCap Group plc (the "Company" and together with its subsidiaries, the "Group") is a public limited company, limited by shares, incorporated and domiciled in England and Wales. The Company was incorporated on 28 August 2018. The registered office of the Company is at 1 Bartholomew Close, London EC1A 7BL, United Kingdom. The registered company number is 11540126. The Company is listed on the AIM of the London Stock Exchange.
These unaudited consolidated Interim Financial Statements have been prepared in accordance with AIM Rule 18. The financial information contained in the Interim Financial Statements is unaudited and does not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006.
The statutory accounts for the 12 months ended 31 March 2022 have been delivered to the Registrar of Companies. The statutory accounts have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards as adopted by the European Union and the IFRS Interpretation Committee interpretations (collectively IFRSs), and in accordance with applicable law. The Independent Auditor's Report to the members of finnCap Group plc contained no qualification or statement under section 498 (2) or (3) of the Companies Act 2006.
These consolidated Interim Financial Statements contain information about the Group and have been prepared on a historical cost basis except for certain financial instruments which are carried at fair value. Amounts are rounded to the nearest thousand, unless otherwise stated and are presented in pounds sterling, which is the currency of the primary economic environment in which the Group operates.
The preparation of these Interim Financial Statements requires the use of certain critical accounting estimates. It also requires Group management to exercise judgement in applying the Group's accounting policies. Judgements and estimates used in these Interim Financial Statements have been applied on a consistent basis with those use in the statutory accounts for the 12 months ended 31 March 2022.
The Directors believe that the Company has adequate resources to continue trading for at least 12 months from the date of approval of this report. Accordingly, they continue to adopt the going concern basis in preparing the Interim Financial Statements.
2. Segmental reporting
The Group is managed as an integrated full-service financial services group and the different revenue streams are considered to be subject to similar economic characteristics. Consequently, the Group is managed as one business unit.
The trading operations of the Group comprise of Corporate Advisory and Broking, Private M&A Advisory and Institutional Stockbroking. The Group's revenues are derived from activities conducted in the UK, although several of its corporate and institutional investors and clients are situated overseas. All assets of the Group reside in the UK.
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
Revenues |
|
|
|
|
Retainers |
|
3,452 |
3,173 |
6,615 |
Transactions |
|
3,912 |
8,688 |
15,767 |
Institutional Stockbroking |
|
1,917 |
3,696 |
5,903 |
Total ECM |
|
9,281 |
15,557 |
28,285 |
Private M&A advisory |
|
7,071 |
16,130 |
24,260 |
Total Revenue |
|
16,352 |
31,687 |
52,545 |
|
|
|
|
|
Services transferred at a point in time |
|
12,100 |
27,254 |
43,462 |
Services transferred over a period of time |
|
4,252 |
4,433 |
9,083 |
Total Revenue |
|
16,352 |
31,687 |
52,545 |
3. Other operating income
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
Other operating income |
|
(138) |
(26) |
13 |
4.
4. Expenses by nature
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
Employee benefit expense |
|
11,329 |
19,958 |
33,081 |
Non-employee costs |
|
5,728 |
5,162 |
10,860 |
Total administrative expenses |
|
17,057 |
25,120 |
43,941 |
|
|
|
|
|
Total number of employees |
|
161 |
135 |
165 |
Employee benefit expense includes share-based payments which decreased to £386k (H1 22: £832k).
5. Non-recurring items
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
Non-recurring items |
|
1,444 |
- |
- |
Non-recurring items in the period relate to group restructuring costs and legal and professional fees in connection with the aborted acquisition of the group by Panmure Gordon Group Limited.
6. Earnings per share
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
Earnings per share |
|
|
|
|
Number of shares |
|
|
|
|
Weighted average number of shares for the purposes |
|
|
|
|
of basic earnings per share |
|
169,041,783 |
162,321,463 |
164,699,708 |
Weighted average dilutive effect of conditional share |
|
|
|
|
awards |
3,011,648 |
18,941,586 |
17,546,548 |
|
Weighted average number of shares for the purposes |
|
|
|
|
of diluted earnings per share |
172,053,431 |
181,263,049 |
182,246,256 |
|
|
|
|
|
|
Profit per ordinary share (pence) |
|
|
|
|
Basic (loss)/profit per ordinary share |
|
(1.82) |
2.96 |
3.95 |
Diluted (loss)/profit per ordinary share |
|
(1.79) |
2.65 |
3.57 |
The shares held by the Group's Employee Benefit Trust have been excluded from the calculation of earnings per share.
7.
7. Dividends
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
Dividends proposed and paid during the year |
- |
1,638 |
2,639 |
|
Dividends per share |
- |
1.00p |
1.60p |
8. Balance sheet items
i) Deferred tax asset
Deferred taxation for the group relates to timing difference on the taxation relief on the exercise of options. The amount of the asset is determined using tax rates that have been enacted or substantively enacted when the deferred tax assets are expected to be recovered.
ii) Trade and other receivables
Trade and other receivable principally consist of amounts due from client, brokers and other counterparties. In addition, the Company has credit risk exposure to the gross value of unsettled trades (on a delivery versus payment basis) at its agency settlement agent (Pershing, a wholly owned subsidiary of Bank of New York Mellon Corporation)
iii) Own shares held
The value of own shares held is the cost of shares purchased the Group's Employee Benefit Trust. The Trust was established with the authority to acquire shares in finnCap Group plc and is funded by the Group.
iv) Merger relief reserve
The merger relief reserve represents:
· the difference between net book value of finnCap Ltd and the nominal value of the shares issued due to the share for share exchange on the acquisition of finnCap Ltd. Upon consolidation, part of the merger reserve is eliminated to recognise the pre-acquisition share premium and capital redemption reserve of finnCap Ltd; and
· the difference between the fair value and nominal value of shares issued for the acquisition of Cavendish Corporate Finance (UK) Limited and Cavendish Corporate Finance LLP
This reserve is not distributable
9. Alternative performance measures
The below non-GAAP alternative performance measures have been used.
Adjusted earnings per share and profit before tax
Measure: Adjusted earnings per share is calculated excluding share-based payments, non-recurring items, amortisation of intangible assets from the acquisition of Cavendish and includes a nominal tax charge adjustment. As with earnings per share, the weighted average number of shares in issue during the period excludes shares held by the Group's Employee Benefit Trust.
Use: Provides a consistent measure of the earnings performance of the core business activities.
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
(Loss)/profit attributable to equity shareholders |
|
(3,079) |
4,798 |
6,511 |
Fair value gains on long term investments |
|
138 |
26 |
- |
Non-recurring items |
|
1,444 |
- |
- |
Share based payments |
|
386 |
832 |
1,100 |
Amortisation |
|
- |
39 |
84 |
Taxation |
|
612 |
48 |
(264) |
Adjusted earnings |
|
(499) |
5,743 |
7,431 |
Basic shares |
|
169,041,783 |
162,321,463 |
164,699,708 |
Earnings per share (basic) |
|
(1.82) |
2.96 |
3.95 |
Adjusted (loss)/earnings per share (basic) |
|
(0.30) |
3.54 |
4.51 |
|
|
6 months ended |
6 months ended |
12 months ended |
|
|
30 September 2022 |
30 September 2021 |
31 March 2022 |
|
|
Unaudited |
Unaudited |
Audited |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
(Loss)/profit before tax |
|
(2,592) |
6,282 |
8,105 |
Fair value gains on long term investments |
|
138 |
26 |
- |
Non-recurring items |
|
1,444 |
- |
- |
Share based payments |
|
386 |
832 |
1,100 |
Amortisation |
|
- |
39 |
84 |
Adjusted (loss)/profit before tax |
|
(624) |
7,179 |
9,289 |
END